நோய் மையங்கள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana
DVIDS - News - Neuropathologist Earns Top Neuropathology Award, Recognized for Career-Long Scientific Achievements
dvidshub.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dvidshub.net Daily Mail and Mail on Sunday newspapers.
New research institute and center launched to advance regenerative medicine in Singapore
eurekalert.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from eurekalert.org Daily Mail and Mail on Sunday newspapers.
US promotes serial testing for COVID-19 with streamlined approval ANI | Updated: Mar 17, 2021 08:30 IST
Washington [US], March 17 (ANI/Sputnik): The US government issued simplified rules for developers of coronavirus tests to promote serial screening, a process in which the same individual is tested multiple times within a few days, the Food and Drug Administration (FDA) said. Today, we are providing information for test developers about a streamlined path to emergency use authorization, the FDA said in a press release on Tuesday. This [path] applies to developers of molecular and antigen tests, for use in serial testing programs, as well as at-home tests for use in a serial manner outside of a testing program.
E-Mail
IMAGE: Nirmal Verma, Ph.D., and several other researchers contributed to the recent study potentially linking low blood amylin levels to reduced progression of Alzheimer s disease. view more
Credit: Photo by Pete Comparoni | UKphoto
LEXINGTON, Ky. (January 20, 2021) - More than 5.7 million Americans live with Alzheimer s disease and that number is projected to triple by 2050. Despite the growing number there is not a cure. Florin Despa a professor with the University of Kentucky s department of pharmacology and nutritional sciences says, The mechanisms underlying neurodegenerative diseases are largely unknown and effective therapies are lacking. That is why numerous studies and trials are ongoing around the world including at the University of Kentucky. One of those studies by University of Kentucky researchers was recently published in
The team’s work shows that early pathological processes in the brains of individuals who are genetically predisposed to develop Alzheimer’s disease are modulated by a pancreatic hormone called amylin. This study is the first to show that the brains of patients with familial AD accumulate amyloid-forming amylin secreted by the pancreas. “Our study suggests an alternative approach to reduce the progression of Alzheimer’s disease through the modulation of blood levels of amylin. In addition, the results of this study can point to the pancreatic hormone amylin as a potential missing molecular link between metabolic disorders and increased risk for Alzheimer’s disease. Specifically, amylin dysregulation contributes to both type-2 diabetes and Alzheimer’s disease.”
vimarsana © 2020. All Rights Reserved.